Lanreotide Acetate
Brand name: Somatuline Depot
Rank #455 of 500 drugs by total cost
$16.7M
Total Cost
1,753
Total Claims
$16.7M
Total Cost
96
Prescribers
$9,551
Cost per Claim
0
Beneficiaries
1,769
30-Day Fills
$174K
Avg Cost/Provider
18
Avg Claims/Provider
About Lanreotide Acetate
Lanreotide Acetate (sold as Somatuline Depot) was prescribed 1,753 times by 96 Medicare Part D providers in 2023, costing the program $16.7M. At $9,551 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 452 | Insulin Degludec/Liraglutide (Xultophy 100-3.6) | $17.1M | 10,644 |
| 453 | Dicyclomine Hcl (Dicyclomine Hcl) | $17.0M | 738,543 |
| 454 | Nitroglycerin (Nitroglycerin) | $16.8M | 768,384 |
| 455 | Lanreotide Acetate (Somatuline Depot) | $16.7M | 1,753 |
| 456 | Clonidine (Clonidine) | $16.7M | 112,710 |
| 457 | Glucagon (Gvoke Hypopen 2-Pack) | $16.6M | 31,523 |
| 458 | Bosentan (Bosentan) | $16.5M | 2,765 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology